Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.25 SEK | +3.39% | +16.86% | +103.33% |
Sales 2023 | 5.68M 530K | Sales 2024 * | 65.65M 6.13M | Capitalization | 791M 73.83M |
---|---|---|---|---|---|
Net income 2023 | -178M -16.61M | Net income 2024 * | -111M -10.36M | EV / Sales 2023 | 48.9 x |
Net cash position 2023 | 111M 10.39M | Net cash position 2024 * | 11.93M 1.11M | EV / Sales 2024 * | 11.9 x |
P/E ratio 2023 |
-2.19
x | P/E ratio 2024 * |
-4.95
x | Employees | 31 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 57.48% |
Latest transcript on IRLAB Therapeutics AB
1 day | +3.39% | ||
1 week | +16.86% | ||
Current month | +33.77% | ||
1 month | +20.08% | ||
3 months | +7.39% | ||
6 months | +124.26% | ||
Current year | +103.33% |
Managers | Title | Age | Since |
---|---|---|---|
Clas Sonesson
FOU | Founder | 63 | 12-12-31 |
Chief Executive Officer | 71 | 17-05-05 | |
Nicholas Waters
FOU | Founder | 62 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jan Anders Vedin
BRD | Director/Board Member | 82 | 15-12-31 |
Rein Piir
BRD | Director/Board Member | 66 | 15-12-31 |
Chairman | 66 | 19-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 15.25 | +3.39% | 100,168 |
24-05-16 | 14.75 | -6.35% | 96,255 |
24-05-15 | 15.75 | -2.78% | 42,681 |
24-05-14 | 16.2 | +3.85% | 119,303 |
24-05-13 | 15.6 | +19.54% | 191,965 |
Delayed Quote Nasdaq Stockholm, May 17, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+103.33% | 73.87M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- IRLAB A Stock